Evolving Clinical Paradigms for LDL Lowering: Focus on Efficacy, Implications, Side Effects, and Safety Results of Clinical Trials Evaluating PCSK9 Inhibition, APOB Suppression, and Other Novel Targets for Primary and Familial Hyperlipidemia - R. Scott Wright, MD

Evolving Clinical Paradigms for LDL Lowering: Focus on Efficacy, Implications, Side Effects, and Safety Results of Clinical Trials Evaluating PCSK9 Inhibition, APOB Suppression, and Other Novel Targets for Primary and Familial Hyperlipidemia - R. Scott Wright, MD

Published

November 16, 2015

Created by

CMEducation Resources symposium